C&L: Kuppers takes over at Pieris Proteolab

Germany's Pieris Proteolab has appointed Evert Kuppers as CEO. Kuppers joins Pieris from IDEA, where he was vice president and head of business development.

NPS Pharmaceuticals has appointed its COO and president, Tony Coles, as its CRO. Coles succeeds Hunter Jackson, who stepped down as the company's chairman and CEO.

Rosetta Genomics announced that Amir Avniel has been named president and CEO of the company.

Celldex Therapeutics has named Robert Forbes Burns, PhD, as CEO.

Cobalis Corp. has named Gerald J. Yakatan, Ph.D., as CEO.

Advanced Viral Research has appointed Stephen M. Elliston as the company's president, CEO and member of the board of directors.

Baxter International has named John J. Greisch to the newly created role of corporate vice president and president, international. Robert M. Davis, currently the company's treasurer, succeeds Greisch as corporate vice president and CFO.

PDI has appointed Jeffrey Smith as its executive vice president, CFO and treasurer.

Axcan Pharma has named Alexandre LeBeaut senior vice president and chief scientific officer. LeBeaut will replace Francois Martin.

Acceleron Pharma has appointed Matthew L. Sherman, M.D. as senior vice president and chief medical officer.

Seattle Genetics has named Pamela A. Trail, Ph.D. as its chief scientific officer.

Panacos Pharmaceuticals has named Frederick Schmid, DVM, MBA, senior vice president, commercial operations and business development.

Genitope Corporation has named Mary Rybak, M.D., as the company's vice president of medical affairs.

Biopure Corporation named A. Gerson Greenburg, M.D., Ph.D. as vice president of medical affairs.

Inyx has hired David Zinn, CPA, as vice president, finance.

Esprit Pharma announced that it has appointed Glenn M. Esgro vice president of trade.

Novavax has named Dr. Jinyou Zhang as senior director of bioprocess R & D. Dr. Niranjan Kumar has been named senior director of commercial manufacturing.

Somaxon Pharmaceuticals has appointed Matthew W. Onaitis as vice president of legal affairs.

Genentech announced two vice president appointments: Michael P. Miller to vice president, sales and marketing, HER Family; and David Schenkein, M.D., to vice president, clinical hematology/oncology.

Novo Nordisk has appointed Pamela Harris, vice president of diabetes sales, managed care and government accounts south/west and Patrick Loustau, vice president of diabetes sales, managed care and government accounts north/midwest.

BrainStorm Cell Therapeutics has engaged Dr. Holly G. Atkinson as contract director of business development.

GlobeImmune has hired Jeffrey Rona as chief business officer.

IBEX Technologies has elected Robert Heft, PhD as director.

Merrimack Pharmaceuticals has added Sarah E. Nash and Steven C. Wheelwright, Ph.D., to its board of directors.

Immucor has added Michael S. Goldman to its board of directors.

MediciNova has appointed Arlene M. Morris and Alan W. Dunton to its board.

Suggested Articles

Wedding Five Prime Therapeutics’ cabiralizumab to Bristol-Myers Squibb’s checkpoint inhibitor Opdivo has proved to be a bust in pancreatic cancer.

Sean Harper and Beth Seidenberg tell FierceBiotech how and why they set up their own VC firm, Westlake Village BioPartners.

Imara is looking to cap a good 2019 with an initial public offering in 2020. The rare disease biotech wants $86 million on the Nasdaq.